Close
Help
signup_email_alerts
Need Help?



Clinical Response of Necrobiotic Xanthogranuloma to Treatment of Underlying Paraproteinemia with Lenalidomide

Submit a Paper


Libertas Analytics


620 Article Views

Publication Date: 24 Oct 2011

Journal: Clinical Medicine Insights: Dermatology

Citation: Clinical Medicine Insights: Dermatology 2011:4 43-46

doi: 10.4137/CMD.S7858

CMId journal

38,984 Article Views

7,152,772 Libertas Article Views

More Statistics

Abstract

Necrobiotic xanthogranuloma (NXG) is a rare, chronic, histiocytic panniculitis associated with underlying paraproteinemia. This paraproteinemia, with monoclonal gammopathy of undetermined significance (MGUS), may be followed without treatment. We report a 62-year-old female with a history of progressive nodular and ulcerated lesions for many years who failed local and intralesional treatments. The skin lesions progressed to ulceration. Her paraprotein levels reduced when the underlying monoclonal gammopathy was treated with lenalidomide and dexamethasone. Healing and resolution of the skin lesions was seen in conjunction with reduction in serum paraprotein levels. Symptomatic skin lesions warrant treatment of the underlying paraproteinemia in the patient with NXG and MGUS. Treatment with lenalidomide and dexamethasone was successful in this patient.


Post a Comment

x close

Discussion Add A Comment
No comments yet...Be the first to comment.


share on

Our Service Promise

  • Prompt Processing (Less Than 3 Weeks)
  • Fair & Comprehensive Peer Review
  • Professional Author Service
  • Leading Editors in Chief
  • Extensive Indexing
  • High Readership & Impact
  • What Your Colleagues Say

Quick Links

Follow Us We make it easy to find new research papers.

BROWSE CATEGORIES